These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 28216085)

  • 21. Occurrence of Clostridium difficile infections in Serbia and high proportion of PCR ribotype 027 strains in two hospitals in Belgrade.
    Jovanović M; Drakulović M; Tošić T; Stošović R; Jovanović S
    Anaerobe; 2018 Jun; 51():64-67. PubMed ID: 29627510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
    Peretz A; Tkhawkho L; Pastukh N; Brodsky D; Halevi CN; Nitzan O
    BMC Infect Dis; 2016 Jun; 16():309. PubMed ID: 27334992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
    BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
    Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
    J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxin profiles, PCR ribotypes and resistance patterns of Clostridium difficile: a multicentre study in China, 2012-2013.
    Gao Q; Wu S; Huang H; Ni Y; Chen Y; Hu Y; Yu Y
    Int J Antimicrob Agents; 2016 Dec; 48(6):736-739. PubMed ID: 27793509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.
    Balassiano IT; Miranda KR; Boente RF; Pauer H; Oliveira IC; Santos-Filho J; Amorim EL; Caniné GA; Souza CF; Gomes MZ; Ferreira EO; Brazier JS; Domingues RM
    Anaerobe; 2009 Jun; 15(3):61-4. PubMed ID: 19154793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
    Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M
    Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012.
    Beran V; Kuijper EJ; Harmanus C; Sanders IM; van Dorp SM; Knetsch CW; Janeckova J; Seidelova A; Barekova L; Tvrdik J; Chmelar D; Ciznar I
    Folia Microbiol (Praha); 2017 Sep; 62(5):445-451. PubMed ID: 28332133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence and diversity of tcdA-negative and tcdB-positive, and non-toxigenic, Clostridium difficile in Thailand.
    Imwattana K; Wangroongsarb P; Riley TV
    Anaerobe; 2019 Jun; 57():4-10. PubMed ID: 30862468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain.
    Weber I; Riera E; Déniz C; Pérez JL; Oliver A; Mena A
    Int J Med Microbiol; 2013 Apr; 303(3):128-33. PubMed ID: 23523477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B; Wojno J; Abratt V; Reid SJ
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
    Doosti A; Mokhtari-Farsani A
    Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of Clostridium difficile infection in a Brazilian cancer hospital.
    Costa CL; Mano de Carvalho CB; González RH; Gifoni MAC; Ribeiro RA; Quesada-Gómez C; Brito GAC
    Anaerobe; 2017 Dec; 48():232-236. PubMed ID: 28987390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.
    Jin D; Luo Y; Huang C; Cai J; Ye J; Zheng Y; Wang L; Zhao P; Liu A; Fang W; Wang X; Xia S; Jiang J; Tang YW
    J Clin Microbiol; 2017 Mar; 55(3):801-810. PubMed ID: 27974547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.
    Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV
    Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
    Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.